The post European Commission Set to Hand Full Crypto Oversight to ESMA appeared first on Coinpedia Fintech News The European crypto world may soon look very different. A major change is quietly taking shape in Brussels. A new reform, now being drafted by the European Commission, aims to give ESMA (European Securities and Markets Authority) full control over licensing and monitoring crypto-asset service providers in all EU countries. If approved, this would replace …The post European Commission Set to Hand Full Crypto Oversight to ESMA appeared first on Coinpedia Fintech News The European crypto world may soon look very different. A major change is quietly taking shape in Brussels. A new reform, now being drafted by the European Commission, aims to give ESMA (European Securities and Markets Authority) full control over licensing and monitoring crypto-asset service providers in all EU countries. If approved, this would replace …

European Commission Set to Hand Full Crypto Oversight to ESMA

2025/11/14 20:21
2 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com
Bitcoin Adoption in the U.S.

The post European Commission Set to Hand Full Crypto Oversight to ESMA appeared first on Coinpedia Fintech News

The European crypto world may soon look very different. A major change is quietly taking shape in Brussels. A new reform, now being drafted by the European Commission, aims to give ESMA (European Securities and Markets Authority) full control over licensing and monitoring crypto-asset service providers in all EU countries.

If approved, this would replace the current system, where each member state handles supervision individually.

EU Plans to Centralize Crypto Regulation

The European Commission is preparing a reform that would give the European Securities and Markets Authority (ESMA) full control over licensing and supervising all crypto-asset service providers across the EU.

Right now, crypto firms only need approval from one member state under the MiCA framework, and that license lets them operate across the entire bloc. This system took years for national regulators and companies to build and was expected to become fully stable by next year.

But the Commission is now considering a major shift: moving all authorisations and oversight to ESMA.

The idea is simple, crypto markets move fast, operate globally, and don’t fit neatly within national borders.

Critics Warn of Regulatory Disruption

Not everyone is welcoming the move. However, several other industry groups say shifting supervision in the middle of MiCA implementation could cause confusion.

Robert Kopitsch from Blockchain for Europe warned that reopening MiCA now risks slowing down the licensing process and creating uncertainty for businesses already preparing for full compliance next year.

He also stressed that national regulators have a closer relationship with companies, something a central authority may struggle to maintain.

Growing Push for a Centralized EU Market

This move isn’t just about crypto. Europe has been trying to centralize financial supervision for years from clearing houses to trading venues. France strongly supports this direction, while other countries fear losing control.

In fact, regulators in France, Italy, and Austria have already called for ESMA to directly oversee major crypto companies, leaving only smaller players under local regulators.

For now, the proposal still needs approval from the European Parliament and all EU member states. The draft will be released next month, and it is expected to spark one of the biggest regulatory debates the European crypto sector has seen.

Market Opportunity
SOON Logo
SOON Price(SOON)
$0,1381
$0,1381$0,1381
-0,28%
USD
SOON (SOON) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Tags:

You May Also Like

Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference

Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference

The post Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference appeared on BitcoinEthereumNews.com. The suitcoiners are in town.  From a low-key, circular podium in the middle of a lavish New York City event hall, Strategy executive chairman Michael Saylor took the mic and opened the Bitcoin Treasuries Unconference event. He joked awkwardly about the orange ties, dresses, caps and other merch to the (mostly male) audience of who’s-who in the bitcoin treasury company world.  Once he got onto the regular beat, it was much of the same: calm and relaxed, speaking freely and with confidence, his keynote was heavy on the metaphors and larger historical stories. Treasury companies are like Rockefeller’s Standard Oil in its early years, Michael Saylor said: We’ve just discovered crude oil and now we’re making sense of the myriad ways in which we can use it — the automobile revolution and jet fuel is still well ahead of us.  Established, trillion-dollar companies not using AI because of “security concerns” make them slow and stupid — just like companies and individuals rejecting digital assets now make them poor and weak.  “I’d like to think that we understood our business five years ago; we didn’t.”  We went from a defensive investment into bitcoin, Saylor said, to opportunistic, to strategic, and finally transformational; “only then did we realize that we were different.” Michael Saylor: You Come Into My Financial History House?! Jokes aside, Michael Saylor is very welcome to the warm waters of our financial past. He acquitted himself honorably by invoking the British Consol — though mispronouncing it, and misdating it to the 1780s; Pelham’s consolidation of debts happened in the 1750s and perpetual government debt existed well before then — and comparing it to the gold standard and the future of bitcoin. He’s right that Strategy’s STRC product in many ways imitates the consols; irredeemable, perpetual debt, issued at par, with…
Share
BitcoinEthereumNews2025/09/18 02:12
Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent?

Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent?

The post Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent? appeared on BitcoinEthereumNews.com. In brief The White House registered aliens.gov
Share
BitcoinEthereumNews2026/03/19 05:33
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26